【Golden Biotechnology】Announcement of the Board of Directors' Approval of the Financial Report for Q1 2026

1. Date of reporting to or resolution by the Board of Directors: 2026/05/08 2. Date of approval by the Audit Committee: 2026/05/08 3. Reporting period for the financial report or annual self-compiled financial information: From (YYYY/MM/DD) to (YYYY/MM/DD): 2026/01/01 to 2026/03/31 4. Operating revenue accumulated from January 1 to the current period (in thousands NTD): 6,278 5. Gross operating profit (or loss) accumulated from January 1 to the current period (in thousands NTD): 3,941 6. Operating income (or loss) accumulated from January 1 to the current period (in thousands NTD): (26,548) 7. Profit before tax (or loss) accumulated from January 1 to the current period (in thousands NTD): (23,094) 8. Net profit (or loss) for the current period accumulated from January 1 to the current period (in thousands NTD): (23,094) 9. Net profit (or loss) attributable to owners of the parent accumulated from January 1 to the current period (in thousands NTD): (23,094) 10. Basic earnings per share (or loss) accumulated from January 1 to the current period (NTD): (0.36) 11. Total assets at period end (in thousands NTD): 920,098 12. Total liabilities at period end (in thousands NTD): 77,100 13. Equity attributable to owners of the parent at period end (in thousands NTD): 842,998 14. Other matters that should be specified: None